Literature DB >> 34825351

Cardiac metastasis after esophagogastrectomy for esophageal adenocarcinoma with an antemortem diagnosis.

Yohsuke Yagawa1, Kosuke Narumiya2, Kenji Kudo1, Shinsuke Maeda1, Yukinori Toyoshima1, Kyohei Ogawa1, Keishi Tanigawa3, Yaichiro Hashimoto4, Yoji Nagashima5, Harushi Osugi1, Hiroto Egawa1.   

Abstract

Cardiac metastasis is uncommon and rarely diagnosed antemortem. Here, we describe a case of symptomatic cardiac metastasis from esophageal adenocarcinoma. A 64-year-old man developed chest symptoms 26 months after curative esophagogastrectomy for esophageal adenocarcinoma. Initially, ischemic cardiac disease was suspected based on electrocardiography findings, but an infiltrative tumor was seen morphologically in the wall of the interventricular septum and apex. No other lesions were detected. Histological examination of a transcatheter biopsy specimen indicated that the cardiac tumor was metastasis from esophageal adenocarcinoma. Chemoradiotherapy with cisplatin relieved his symptoms, and he had resumed normal activities. However, he opted not to undergo further aggressive treatment due to severe adverse effects from cisplatin. Seventeen months after completion of chemoradiotherapy, metastases to the right ventricle and the left thighbone were detected and he died 27 and 24 months after the diagnosis of cardiac metastasis and completion of chemoradiotherapy, respectively.
© 2021. Japanese Society of Gastroenterology.

Entities:  

Keywords:  18F-FDG PET/CT under low carbohydrate condition; Cardiac metastasis; Chemoradiotherapy; Esophageal adenocarcinoma; Secondary cardiac disease

Mesh:

Year:  2021        PMID: 34825351     DOI: 10.1007/s12328-021-01557-6

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  7 in total

1.  Oesophageal cancer with myocardial metastasis complicated by ventricular fibrillation: the role of echocardiography.

Authors:  Can Yucel Karabay; Gonenc Kocabay; Cuneyt Toprak; Cevat Kirma
Journal:  Kardiol Pol       Date:  2012       Impact factor: 3.108

2.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

Authors:  H Engel; H Steinert; A Buck; T Berthold; R A Huch Böni; G K von Schulthess
Journal:  J Nucl Med       Date:  1996-03       Impact factor: 10.057

3.  Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.

Authors:  L Seymour; V Bramwell; L A Moran
Journal:  Cancer Prev Control       Date:  1999-04

4.  The incidence of secondary tumors of the heart and pericardium: a 10-year study.

Authors:  K Mukai; T Shinkai; K Tominaga; Y Shimosato
Journal:  Jpn J Clin Oncol       Date:  1988-09       Impact factor: 3.019

5.  [Cardia cancer: attempt at a therapeutically relevant classification].

Authors:  J R Siewert; A H Hölscher; K Becker; W Gössner
Journal:  Chirurg       Date:  1987-01       Impact factor: 0.955

6.  Asymptomatic Cardiac Metastasis in a Diagnosed Case of Squamous Cell Carcinoma of the Middle Third of Esophagus.

Authors:  H S Sachin; Preethi Shetty; C S Pramesh; Sarbani Ghosh Laskar
Journal:  Indian J Palliat Care       Date:  2018 Jul-Sep

7.  Asymptomatic Cardiac Metastases From Esophageal Cancer: A Case Report Of Ante-mortem Detection And Literature Review.

Authors:  Carlo Signorelli; Amedeo Pergolini; Giordano Zampi; Andrea Vallone; Enzo Maria Ruggeri
Journal:  Cureus       Date:  2019-12-15
  7 in total
  1 in total

1.  Predictive effect of J waves on cardiac compression and clinical prognosis of esophageal tumors: a retrospective study.

Authors:  Songcui Shen; Yichen Xie; Pengliang Ju; Wenzhao Li; Jiayuan Zhang; Ruxin Cai; Ruogu Li
Journal:  J Gastrointest Oncol       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.